Human endothelin-bombesin receptor
AssigneeHuman Genome Sciences, Inc.
InventorsYi Li, Craig A. Rosen, Chandrika Kumar
Life of this patent
Estimating the term…
Loading patent…
AssigneeHuman Genome Sciences, Inc.
InventorsYi Li, Craig A. Rosen, Chandrika Kumar
Estimating the term…
A human endothelin-bombesin receptor polypeptide and DNA (RNA) encoding such polypeptide and a procedure for producing such polypeptide by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptide for identifying agonists and antagonists to such polypeptide. Agonists to the endothelin-bombesin receptor polypeptide of the present invention may be used to treat asthma, Parkinson's Disease, acute heart failure, hypotension and osteoporosis. Antagonists against such polypeptides may be used therapeutically to treat hypertension, ulcerigenesis, subarachnoid hemorrhage, asthma, tumors, ciclosporin toxicity, cancer and septic shock. Also disclosed are diagnostic methods for detecting mutations in the polynucleotides of the present invention and for detecting levels of the soluble polypeptides in samples derived from a host.
An isolated protein molecule comprising an amino acid sequence selected from the group consisting of:
An isolated protein molecule comprising an amino acid sequence selected from the group consisting of:
An isolated protein molecule comprising an amino acid sequence selected from the group consisting of:
Dependencies are inferred from the claim text.